News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,586 Results
Type
Article (43189)
Company Profile (276)
Press Release (694104)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (206993)
Career Advice (2060)
Deals (35883)
Drug Delivery (128)
Drug Development (81873)
Employer Resources (173)
FDA (16625)
Job Trends (15167)
News (350141)
Policy (33214)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2676)
Academic (1)
Accelerated approval (45)
Adcomms (26)
Allergies (170)
Alliances (50390)
ALS (203)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (428)
Approvals (16984)
Artificial intelligence (637)
Autoimmune disease (257)
Automation (53)
Bankruptcy (366)
Best Places to Work (11705)
BIOSECURE Act (20)
Biosimilars (217)
Biotechnology (178)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (727)
Cancer (5690)
Cardiovascular disease (461)
Career advice (1750)
Career pathing (42)
CAR-T (317)
CDC (55)
Celiac Disease (3)
Cell therapy (850)
Cervical cancer (47)
Clinical research (70774)
Collaboration (2032)
Company closure (5)
Compensation (1332)
Complete response letters (77)
COVID-19 (2784)
CRISPR (105)
C-suite (1077)
Cystic fibrosis (150)
Data (7555)
Decentralized trials (3)
Denatured (28)
Depression (158)
Dermatology (76)
Diabetes (576)
Diagnostics (7080)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (199)
Drug shortages (31)
Duchenne muscular dystrophy (275)
Earnings (91918)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (119873)
Executive appointments (1071)
FDA (20246)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1693)
Gene editing (228)
Generative AI (54)
Gene therapy (687)
GLP-1 (1050)
Government (4766)
Grass and pollen (6)
Guidances (403)
Healthcare (19107)
HIV (79)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (282)
Immuno-oncology (86)
Indications (176)
Infectious disease (3122)
Inflammatory bowel disease (205)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (285)
Interviews (322)
IPO (16729)
IRA (50)
Job creations (3768)
Job search strategy (1457)
JPM (59)
Kidney cancer (18)
Labor market (96)
Layoffs (562)
Leadership (38)
Legal (8074)
Liver cancer (99)
Longevity (32)
Lung cancer (756)
Lymphoma (421)
Machine learning (58)
Management (59)
Manufacturing (995)
MASH (180)
Medical device (13970)
Medtech (14068)
Mergers & acquisitions (20373)
Metabolic disorders (1465)
mRNA (198)
Multiple sclerosis (183)
NASH (18)
Neurodegenerative disease (401)
Neuropsychiatric disorders (103)
Neuroscience (3259)
Neurotech (1)
NextGen: Class of 2026 (6560)
Non-profit (4587)
Now hiring (76)
Obesity (685)
Opinion (288)
Ovarian cancer (209)
Pain (247)
Pancreatic cancer (291)
Parkinson's disease (353)
Partnered (34)
Patents (582)
Patient recruitment (643)
Peanut (62)
People (60114)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22076)
Phase 2 (31154)
Phase 3 (23193)
Pipeline (7950)
Policy (308)
Postmarket research (2588)
Preclinical (9484)
Press Release (67)
Prostate cancer (291)
Psychedelics (52)
Radiopharmaceuticals (319)
Rare diseases (1035)
Real estate (6178)
Recruiting (70)
Regulatory (25576)
Reports (55)
Research institute (2473)
Resumes & cover letters (354)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (177)
Series A (282)
Series B (207)
Service/supplier (11)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (50)
Startups (3679)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (61)
Vaccines (1084)
Venture capital (103)
Weight loss (443)
Women's health (120)
Worklife (20)
Date
Today (112)
Last 7 days (761)
Last 30 days (2859)
Last 365 days (30340)
2026 (10644)
2025 (30315)
2024 (35411)
2023 (40332)
2022 (51425)
2021 (56011)
2020 (54492)
2019 (46966)
2018 (35321)
2017 (32504)
2016 (31976)
2015 (38001)
2014 (31862)
2013 (26983)
2012 (29108)
2011 (29780)
2010 (27821)
Location
Africa (757)
Alabama (92)
Alaska (7)
Arizona (346)
Arkansas (14)
Asia (40409)
Australia (6634)
California (12853)
Canada (3680)
China (1303)
Colorado (549)
Connecticut (555)
Delaware (391)
Europe (87682)
Florida (1926)
Georgia (412)
Hawaii (3)
Idaho (62)
Illinois (1027)
India (88)
Indiana (587)
Iowa (23)
Japan (515)
Kansas (130)
Kentucky (51)
Louisiana (39)
Maine (75)
Maryland (1548)
Massachusetts (9157)
Michigan (354)
Minnesota (701)
Mississippi (6)
Missouri (153)
Montana (36)
Nebraska (29)
Nevada (140)
New Hampshire (85)
New Jersey (3406)
New Mexico (29)
New York (3377)
North Carolina (1647)
North Dakota (8)
Northern California (6398)
Ohio (391)
Oklahoma (23)
Oregon (42)
Pennsylvania (2586)
Puerto Rico (28)
Rhode Island (50)
South America (1142)
South Carolina (85)
South Dakota (2)
Southern California (5069)
Tennessee (206)
Texas (2035)
United States (45471)
Utah (385)
Vermont (1)
Virginia (308)
Washington D.C. (80)
Washington State (1032)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
737,586 Results for "eurofins lancaster laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing
April 17, 2026
·
1 min read
Press Releases
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities
February 10, 2026
·
2 min read
Press Releases
Eurofins Scientific : Director/PDMR Shareholding - February 16, 2026
February 16, 2026
·
4 min read
Press Releases
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples
March 11, 2026
·
2 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
Press Releases
Eurofins Viracor Launches ExPeCT™ anti-CD19 (obe-cel) CAR T-Cell Assay to Advance Proactive Monitoring in Next-Generation Immunotherapy
March 27, 2026
·
2 min read
Press Releases
Eurofins Viracor Launches Assays for Pneumococcal Antibody Detection, Expanding Serotype Coverage to Support Immunocompromised Patient Care
January 21, 2026
·
3 min read
Press Releases
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
February 5, 2026
·
2 min read
Press Releases
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study
March 10, 2026
·
4 min read
Press Releases
Eurofins Viracor BioPharma Announces Relocation to New State-of-the-Art Facility
September 1, 2025
·
2 min read
1 of 73,759
Next
